Mark Jacobs
Impact in
- Microbiology top 5%
- Reproductive tract infections research
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- Reproductive tract infections research 3
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Marc S. Ernstoff (1 shared paper)F. Ann Hayes (1 shared paper)Lynn E. S̄pitler (1 shared paper)Seng Jaw Soong (1 shared paper)Michael L. Grossbard (1 shared paper)Jon Ruckle (1 shared paper)Kathryn Underwood (1 shared paper)Carolyn H. Condon (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Obstetrics and Gynecology (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Journal of Clinical Oncology (1 paper)Gastrointestinal Endoscopy (1 paper)
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Mark Jacobs
11 papers receiving 682 citations
Peers
Comparison fields: 5 of 71
- Microbiology 84
- Infectious Diseases 188
- Immunology 182
- Oncology 209
- Hematology 88
Countries citing papers authored by Mark Jacobs
This map shows the geographic impact of Mark Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jacobs more than expected).
Fields of papers citing papers by Mark Jacobs
This network shows the impact of papers produced by Mark Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jacobs. The network helps show where Mark Jacobs may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 227 | |
| 2 | 2008 | 188 | |
| 3 | 2018 | 170 | |
| 4 | 2021 | 68 | |
| 5 | 2014 | 20 | |
| 6 | 2004 | 11 | |
| 7 | 2004 | 10 | |
| 8 | 1989 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 1990 | 3 | |
| 11 | 2023 | 2 |
About Mark Jacobs
Mark Jacobs is a scholar working on Microbiology, Infectious Diseases, Virology, Oncology and Hepatology, having authored 11 papers that have together received 716 indexed citations. Recurring topics across this work include Reproductive tract infections research (3 papers), HIV/AIDS drug development and treatment (2 papers), TGF-β signaling in diseases (1 paper), Bone health and treatments (1 paper), HIV Research and Treatment (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Cancer and Skin Lesions (1 paper) and Gallbladder and Bile Duct Disorders (1 paper). The work is most often cited by research in Microbiology (84 citations), Infectious Diseases (188 citations), Immunology (182 citations), Oncology (209 citations) and Hematology (88 citations). Mark Jacobs has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Marc S. Ernstoff, F. Ann Hayes, Lynn E. S̄pitler, Seng Jaw Soong, Michael L. Grossbard, Jon Ruckle, Kathryn Underwood, Carolyn H. Condon, Matthew Leigh Sherman and William G. Kramer. Their work appears in journals such as Clinical Infectious Diseases, Obstetrics and Gynecology, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Clinical Oncology and Gastrointestinal Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.